Stay updated on Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedClinicalTrials.gov’s page release has been updated from Revision v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedReplaced Padua, Italy, 35128 with Padova, Italy, 35128 in the location entry to reflect the correct city name.SummaryDifference0.0%

- Check46 days agoChange DetectedNaples, Italy (80131) was added to the list of study locations and Napoli was replaced with Naples. The page also shows a new Revision: v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page.SummaryDifference0.0%

- Check82 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.